All In Biotech

Drug Trial Radar · NCT00390585

Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)

Prospective, Randomized, Comparative Study to Evaluate the Effect of Iodixanol 320 Compared to Iomeprol 350 on Contrast Medium Induced Nephropathy in Patients With Impaired Renal Function Undergoing PCI

Last checked: Nov 19, 2026Latest source record: Mar 15, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 324 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

324

Actual

Start

Jul 2006

Primary completion

Jan 2008

Study completion Dec 2008

Sponsor

Lead sponsor
Deutsches Herzzentrum MuenchenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 20, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate that Iodixanol 320 is associated with a lower incidence of contrast-induced nephropathy (CIN) when compared with hyperosmolar contrast medium Iomeprol 350 in patients with impaired renal function undergoing percutaneous coronary interventions (PCI).

Conditions

  • Renal Insufficiency, Chronic
  • Angioplasty, Transluminal, Percutaneous Coronary
  • Coronary Arteriosclerosis

Interventions

  • Iodixanol 320Drug

    Iodixanol 320 is used as contrast media while coronary intervention.

  • Iomeprol 350Drug

    Iomeprol 350 is used as contrast media while coronary intervention.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Contrast-induced nephropathy after percutaneous coronary intervention during primary hospitalizationTime frame: primary hospitalization

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • 1. Medizinische Klinik, Klinikum rechts der Isar

    München, Germany

  • Deutsches Herzzentrum Muenchen

    Munich, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.